Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Cuprina Holdings (Cayman) Limited Class A ( (CUPR) ) just unveiled an update.
On March 11, 2026, Cuprina announced that its 49%-owned associate, Cuprina MENA Co. Ltd, obtained official Saudi Food and Drug Authority classification for MEDIFLY, its medical-grade maggot debridement therapy, as a Medical Device–Drug combination, clearing the way to finalize scientific and technical requirements for commercial distribution across Saudi Arabia’s healthcare network. The company also moved to reinforce its clinical credibility and regional presence by appointing endocrinologist Dr. Enming Yong to its Medical and Scientific Advisory Board and engaging clinicians through recent wound-care focused events in Hong Kong and Singapore, including its inaugural advisory board meeting on March 2, 2026.
The most recent analyst rating on (CUPR) stock is a Sell with a $0.40 price target. To see the full list of analyst forecasts on Cuprina Holdings (Cayman) Limited Class A stock, see the CUPR Stock Forecast page.
Spark’s Take on CUPR Stock
According to Spark, TipRanks’ AI Analyst, CUPR is a Neutral.
The score is driven primarily by weak financial performance (sharp revenue decline, negative margins, negative equity, and negative operating/free cash flow). Technicals also remain bearish with the stock below major moving averages and a negative MACD. Valuation provides limited support given the negative P/E and no dividend yield data.
To see Spark’s full report on CUPR stock, click here.
More about Cuprina Holdings (Cayman) Limited Class A
Cuprina Holdings (Cayman) Limited is a Singapore-based biomedical and biotechnology company focused on developing and commercializing products for chronic wound management, infertility, medical waste recycling and cosmeceuticals. The company leverages natural-source biomaterials to produce medical device-standard wound care solutions for international healthcare markets, including Asia and the Middle East.
Average Trading Volume: 210,000
Technical Sentiment Signal: Strong Sell
Current Market Cap: $2.73M
See more insights into CUPR stock on TipRanks’ Stock Analysis page.